Cost and Quality

Latest KFF Health News Stories

In Grandma’s Stocking: An Apple Watch To Monitor Falls, Track Heart Rhythms

KFF Health News Original

The new-generation gadget is designed to alert and protect wearers from falls and heart problems, expanding Apple’s target audience beyond the usual, tech-savvy, early adopters to those with older tickers.

Listen: Paying More For Your Health Insurance? Depends On Where You Live

KFF Health News Original

As consumers weigh health insurance options during open enrollment, location matters. Some parts of the country are seeing drops in premiums while others are experiencing another year of sticker shock.

Podcast: KHN’s ‘What The Health?’ Reading The Tea Leaves In Blue Wave’s Wake

KFF Health News Original

In this episode of KHN’s “What the Health?” Mary Agnes Carey of Kaiser Health News, Margot Sanger-Katz of The New York Times, Alice Ollstein of Politico and Anna Edney of Bloomberg News discuss the impact of House Democratic leadership elections and their impact on health policy; as well as efforts by the Trump administration to address high drug prices and ensure the safety of medical devices. Plus, Julie Rovner interviews KHN’s Jay Hancock about the latest “Bill of the Month.”

Watch: Why Infusion Drugs Come With Sticker Shock

KFF Health News Original

The story of an Ohio mom who faced an outrageous bill for a new medicine for multiple sclerosis is the latest installment in the “Bill of the Month” series, an ongoing crowdsourced investigation by KHN and NPR.

Chronically Ill, Traumatically Billed: The $123,000 Medicine For MS

KFF Health News Original

Shereese Hickson’s doctor wanted her to try the infusion drug Ocrevus for her multiple sclerosis. Even though Hickson is trained as a medical billing coder, she was shocked to see two doses of the drug priced at $123,019, with her share set at $3,620.

Fish Oil Drug Looks Heart-Healthy. Just Don’t Swallow It Hook, Line And Sinker.

KFF Health News Original

The complete findings of a recent study show the FDA-approved drug Vascepa reduced the likelihood of cardiovascular death, stroke and other heart conditions in some patients. But science didn’t find the same promise for over-the-counter fish oil supplements when tested in healthy people.

Buyers Of Short-Term Health Plans: Wise Or Shortsighted?

KFF Health News Original

Policyholders reason that their health is good — for now — and they don’t see the need for costly comprehensive coverage. Detractors say the plans undermine the Affordable Care Act, and agents advise reading the fine print. “You basically have to be in perfect health,” says one.

Measure To Cap Dialysis Profits Pummeled After Record Spending By Industry

KFF Health News Original

The dialysis industry raised nearly $111 million in a successful bid to defeat the measure, which also was opposed by hospitals and doctors. The union that sponsored the measure collected about one-sixth that amount.